All Roll Calls
Yes: 295 • No: 3
Sponsored By: Dennis Lenz (Republican)
Became Law
Personalized for You
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
4 provisions identified: 4 benefits, 0 costs, 0 mixed.
In Montana, health insurers cannot require prior authorization for several psychiatric medicines. This includes any long‑acting injectable antipsychotic and any psychiatry drug on the state’s quarterly FDA shortage list. They also cannot require it solely because your doctor adjusts the dose within FDA‑approved or common clinical dosing. They cannot require it after you have taken the same noncontrolled generic at the same quantity for 6 months without a break. They cannot make you repeat it for therapeutic duplication when the same drug and dose was already approved.
Drug makers cannot use predatory pricing or marketing for psychiatry drugs that the law lists as in shortage. The state can enforce this and seek penalties under Montana consumer law.
On April 1, July 1, October 1, and January 1, Montana sets a fixed list of psychiatry drugs in shortage. The list comes directly from the FDA shortage list on those dates and stays in place until the next quarter.
In Montana, if an insurer denies a prior authorization for a drug, a doctor who treats that condition must make the denial. Approvals do not need that specialist review.
Dennis Lenz
Republican • Senate
Kerri Seekins-Crowe
Republican • House
Wylie Galt
Republican • Senate
All Roll Calls
Yes: 295 • No: 3
Senate vote • 4/11/2025
Do Concur
Yes: 98 • No: 1
Senate vote • 4/10/2025
Do Concur
Yes: 99 • No: 0
Senate vote • 3/5/2025
Do Pass
Yes: 49 • No: 1
Senate vote • 3/4/2025
Do Pass
Yes: 49 • No: 1
Chapter Number Assigned
Signed by Governor
Transmitted to Governor
Signed by Speaker
Signed by President
Returned from Enrolling
Sent to Enrolling
3rd Reading Concurred
2nd Reading Concurred
Committee Report--Bill Concurred
Committee Executive Action--Bill Concurred
Hearing
First Reading
Referred to Committee
Transmitted to House
3rd Reading Passed
2nd Reading Passed
Committee Report--Bill Passed as Amended
Committee Executive Action--Bill Passed as Amended
Fiscal Note Printed
Fiscal Note Signed
Fiscal Note Received
Hearing
Fiscal Note Requested
Referred to Committee
Enrolled
4/15/2025
As Amended (Version 2)
3/1/2025
Introduced
2/13/2025